Showing 1 - 10 of 11
News, Paritta Wangkiat, Published on 22/09/2014
» Eight years of polypharmacy — the use of multiple medications simultaneously — made Mariam Sriruangtong, 65, unable to walk.
News, Paritta Wangkiat, Published on 06/08/2014
» Four expensive medicines for breast cancer, hepatitis C and leukemia have been added to the national drug lists.
News, Paritta Wangkiat, Published on 08/07/2014
» Health activist groups have urged the National Council for Peace and Order (NCPO) to sack board members of the Government Pharmaceutical Organisation (GPO) for alleged poor performance and corruption related problems.
News, Paritta Wangkiat, Published on 20/05/2014
» Health activists are calling for the social security scheme (SSS) to be overhauled to bring it up to the standard of other national healthcare schemes.
News, Paritta Wangkiat, Published on 13/05/2014
» The National Health Security Office (NHSO) has negotiated with two pharmaceutical companies to reduce the price of hepatitis C drugs by 70%.
News, Paritta Wangkiat, Published on 19/03/2014
» A third of tuberculosis (TB) sufferers in Thailand are not receiving proper treatment, increasing the risk of spreading the disease and their chances of becoming resistant to multiple treatment drugs.
News, Paritta Wangkiat, Published on 03/03/2014
» Health professionals have called on the government to arrange better access to state health services for patients with rare diseases.
News, Paritta Wangkiat, Published on 26/06/2013
» A network working on reducing the harm caused by drug abuse yesterday demanded the government stop using violence and discrimination against drug addicts.
News, Paritta Wangkiat, Published on 25/06/2013
» The Public Health Ministry has ordered the Food and Drug Administration (FDA) and Medical Sciences Department to conduct lab tests on packed rice samples collected from retail outlets, including department stores.
News, Paritta Wangkiat, Published on 20/06/2013
» The National Health Security Office (NHSO) plans to distribute third-line anti-retroviral drugs next year because of a spike in drug-resistant HIV cases.